Shenkman Capital Management Inc HALOZYME THERAPEUTICS INC Transaction History

Shenkman Capital Management Inc

23,289,000

Previous 17,141,000 35.87%

Previous $0 NaN%

0.0%

Previous 0.0%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	N/A	6,148,000 Added 35.87%	23,289,000 $0
Q2 2024 Aug 08, 2024	BUY	N/A	8,772,000 Added 104.82%	17,141,000 $0
Q1 2024 May 09, 2024	BUY	N/A	409,000 Added 5.14%	8,369,000 $0
Q4 2023 Feb 08, 2024	SELL	N/A	-1,059,000 Reduced 11.74%	7,960,000 $0
Q3 2023 Nov 13, 2023	BUY	N/A	404,000 Added 4.69%	9,019,000 $0
Q2 2023 Aug 10, 2023	SELL	N/A	-319,000 Reduced 3.57%	8,615,000 $0
Q1 2023 May 15, 2023	SELL	N/A	-3,469,000 Reduced 27.97%	8,934,000 $0
Q4 2022 Feb 13, 2023	BUY	N/A	4,124,000 Added 49.81%	12,403,000 $0
Q3 2022 Nov 10, 2022	BUY	N/A	8,279,000 New	8,279,000 $7.01 Million
Q2 2022 Aug 11, 2022	BUY	N/A	7,889,000 New	7,889,000 $6.92 Million

Get notified when there are updates to the investment portfolio of Shenkman Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Shenkman Capital Management Inc with notifications on news.